HCA Healthcare (NYSE:HCA) Lowered to “Market Perform” Rating by Raymond James

Raymond James lowered shares of HCA Healthcare (NYSE:HCA) from an outperform rating to a market perform rating in a report issued on Friday, MarketBeat Ratings reports.

Other equities analysts have also issued research reports about the stock. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 6th. Finally, Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Six research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Trading Down 2.2 %

NYSE:HCA opened at $324.92 on Friday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare has a 12 month low of $245.84 and a 12 month high of $417.14. The business’s 50-day moving average is $379.40 and its two-hundred day moving average is $358.05. The firm has a market capitalization of $82.30 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 1.28 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Buying and Selling

In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. Corporate insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Several institutional investors have recently modified their holdings of the company. Terra Nova Asset Management LLC grew its position in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares during the period. Massmutual Trust Co. FSB ADV raised its holdings in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares during the last quarter. Waldron Private Wealth LLC increased its position in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after acquiring an additional 29 shares in the last quarter. Brookstone Capital Management lifted its stake in shares of HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after acquiring an additional 30 shares during the period. Finally, UMB Bank n.a. lifted its stake in shares of HCA Healthcare by 2.4% in the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.